Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02227199
Brief Title: Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (BV-ICE)

First Submitted : August 25, 2014
First Submitted that Met QC Criteria : August 25, 2014
First Posted : August 28, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 16, 2019
Last Update Posted : September 18, 2019